We would like to place cookies onto your computer to help make this website better. Without them, this site would not function correctly or be able to collect information to make your experience better. By continuing to use this site, we'll assume you're OK with this.
RVV activated factor X isolated from fresh human plasma, with subsequent removal of activator and activation peptides.The specific activity is lot dependent
..
Prepared by the activation of factor XI by factor XIIa. Factor XIIa is removed from the activation mixture by immunoadsorption on a column of immobilized anti-factor XIIa.
..
Factor XIII Deficient Plasma is manufactured from pooled normal human plasma defibrinated under controlled conditions, using purified human thrombin. Only the highest quality citrated plasma is used as starting material.
..
Fibrinogen Deficient Plasma is manufactured from pooled normal human plasma defibrinated under controlled conditions, using purified human thrombin. Only the highest quality citrated plasma is used as starting material.
..
Human glu-plasminogen (88 kDa) is prepared from fresh human citrated plasma by lysine-Sepharose affinity chromatography in the presence of aprotinin to minimize any plasmin contamination. This is followed by gel filtration with Sephacryl 200. Treatment with aprotinin-Sepharose is carried out prior t..
This polyclonal antibody reacts with human Plasminogen-Activator-Inhibitor Type-1 (PAI-1), it is suitable for ELISA, Western blot, and Immunohistochemistry
..
This polyclonal antibody reacts with human Plasminogen-Activator-Inhibitor Type-2 (PAI-2), it is suitable for ELISA, Western blot, and Immunohistochemistry
..
This high titer antibody recognizes purified apoprotein of tissue factor, neutralizing lipidated tissue factor along with native tissue factor (Thromboplastin) derived from human brain as well as other sources of natural tissue factor (i.e. placenta acetone powder, tumor cells, LPS-stimulated monocy..